Search results
Results from the WOW.Com Content Network
The Journal of Neuroimaging is a bimonthly peer-reviewed scientific journal covering al aspects of neuroimaging. It was established in 1991 and is published by John Wiley & Sons on behalf of the American Society of Neuroimaging. Since 2015, the editor-in-chief is Rohit Bakshi (Harvard Medical School). The founding editor-in-chief was Leon Prockop.
The mainstay of treatment for schizophrenia is an antipsychotic medication. [5] Most antipsychotics can take around 7 to 14 days to have their full effect. Medication may improve the positive symptoms of schizophrenia, and social and vocational functioning. [ 6 ]
NeuroImage is a peer-reviewed scientific journal covering research on neuroimaging, including functional neuroimaging and functional human brain mapping. The most recent editor-in-chief was Stephen Smith. The journal drew attention in 2023 when all editors resigned after a dispute with the publisher, Elsevier, over publication fees.
Schizophrenia Research is a peer-reviewed medical journal covering research on the cause, clinical diagnostics, and treatment of schizophrenia. It is an official journal of the Schizophrenia International Research Society and was established in 1988. The editor-in-chief is Matcheri Keshavan and the former editors are Henry Nasrallah (University ...
Insulin coma therapy was a labour-intensive treatment that required trained staff and a special unit. [2] Patients, who were almost invariably diagnosed with schizophrenia, were selected on the basis of having a good prognosis and the physical strength to withstand an arduous treatment. [5] There were no standard guidelines for treatment.
Comparable findings in longitudinal studies show: "Particular emphasis is given to methodological limitations in the existing literature, including lack of reliability data, clinical heterogeneity among studies, and inadequate study designs and statistic," suggestions are made for improving future longitudinal neuroimaging studies of treatment ...
The result means that, of these, 21 will not be identified as having schizophrenia by use of FRS (43% of 48). Then, of the 52 people really without schizophrenia, 10 may be incorrectly diagnosed with schizophrenia by the FRS. Diagnosis of schizophrenia from other types of psychosis Sensitivity 58.0 (50.3, 65.3) Specificity 74.7 (85.2, 82.3)
ECT is widely used worldwide in the treatment of schizophrenia, but in North America and Western Europe it is invariably used only in treatment resistant schizophrenia when symptoms show little response to antipsychotics; there is comprehensive research evidence for such practice. [55]